14-day Premium Trial Subscription Sign Up For FreeGet Free

Atossa Genetics Inc. Stock Forecast NASDAQ:ATOS

Price Target and Analyst Ratings

Most Recent Rating

Maxim Group is very positive about ATOS and gave it a "Buy" rating on September 18, 2020. The price target was set to $8.00.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2020-09-18 Buy Reiterated by Maxim Group $2.44 $8.00
2020-09-17 Buy Initiated by Ascendiant Capital Markets $2.32 $7.00
2020-07-31 Buy Reiterated by Maxim Group $3.78 $8.00
2020-07-17 Target Raised by Maxim Group $4.24 $4.00 → $8.00
2020-07-16 Positive Reiterated by Maxim Group $4.00

ATOS Stock Trend

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -42.46% during the next 3 months and, with a 90% probability hold a price between $0.50 and $2.91 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2021-09-23 $0.81 $2.91 $5.00
2021-09-24 $0.76 $2.85 $4.94
2021-09-27 $0.70 $2.79 $4.88
2021-09-28 $0.64 $2.73 $4.82
2021-09-29 $0.58 $2.67 $4.77
2021-09-30 $0.52 $2.61 $4.71
2021-10-01 $0.46 $2.55 $4.65
2021-10-04 $0.40 $2.49 $4.59
2021-10-05 $0.34 $2.43 $4.53
2021-10-06 $0.28 $2.37 $4.47
2021-10-07 $0.22 $2.32 $4.41
2021-10-08 $0.16 $2.26 $4.35
2021-10-11 $0.10 $2.20 $4.29
2021-10-12 $0.0436 $2.14 $4.23
2021-10-13 $-0.0157 $2.08 $4.17
2021-10-14 $-0.0750 $2.02 $4.11
2021-10-15 $-0.13 $1.96 $4.05
2021-10-18 $-0.19 $1.90 $3.99
2021-10-19 $-0.25 $1.84 $3.94
2021-10-20 $-0.31 $1.78 $3.88
2021-10-21 $-0.37 $1.72 $3.82
2021-10-22 $-0.43 $1.66 $3.76
2021-10-25 $-0.49 $1.60 $3.70
2021-10-26 $-0.55 $1.54 $3.64
2021-10-27 $-0.61 $1.49 $3.58
2021-10-28 $-0.67 $1.43 $3.52
2021-10-29 $-0.73 $1.37 $3.46
2021-11-01 $-0.79 $1.31 $3.40
2021-11-02 $-0.85 $1.25 $3.34
2021-11-03 $-0.91 $1.19 $3.28

About Atossa Genetics Inc.

Atossa Genetics Atossa Genetics Inc., a clinical-stage pharmaceutical company, focuses on developing novel therapeutics and delivery methods to treat breast cancer and other breast conditions in the United States. The company is conducting a Phase II clinical study using microcatheters to deliver fulvestrant as a potential treatment of ductal carcinoma in-situ and breast cancer; and a pharmaceutical program under development is Afimoxifene Topical Gel for the tr... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT